CLINICAL_TRIALS trial_result · 2023-12-21

Clinical Trial Update: Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis [Phase 2, Phase 3]

Phase 2/3 trial results for TP-03 in blepharitis have been completed with results posted in late 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Tarsus Pharmaceuticals, Inc. | Conditions: Blepharitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-12-21